HOME >> MEDICINE >> NEWS
Risks of sulfonylurea drugs in the treatment of diabetes mellitus

Sulfonylurea drugs, used in the treatment of patients with diabetes mellitus to lower blood sugar levels, have been suspected since the 1970s of increasing cardiovascular mortality as well.

In this careful study, some 5800 patients treated with pills for their diabetes were monitored for an average of about 5 years. Patients who were prescribed a sulfonylurea drug (chlorpropamide, tolbutamide or glyburide) experienced higher mortality rates than those who received metformin. Mortality from all causes and deaths attributable to heart attacks were both higher among patients taking sulfonylureas. Patients taking higher doses and those with better prescription compliance were more likely to die than those prescribed lower doses or who took less of their medication.


'"/>

Contact: Jeffrey A. Johnson
jeff.johnson@ualberta.ca
Canadian Medical Association Journal
16-Jan-2006


Page: 1

Related medicine news :

1. Risks of gastrointestinal ulcers linked to aspirin use might outweigh its benefits for the heart
2. Risks of taking sedatives for insomnia in older people may be greater than the benefits
3. Risks outweigh benefits of shark cartilage as anti-cancer treatment
4. UIC researchers to develop new drugs to fight bioterrorism
5. Statin drugs may delay progressive artery damage in children
6. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
7. Experts call for urgent research into anti-epileptic drugs given to children
8. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
9. Antipsychotic drugs increase risk of death in older people with dementia
10. Antipsychotic drugs increase risk of death in older people with dementia
11. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Risks sulfonylurea drugs the treatment diabetes mellitus

(Date:5/20/2013)... VHA Inc., the national health care ... population health improvement, announced a new offering to ... pursue population health management with a strategic ... the transition to value-based models of care. As ... of services, the offering integrates VHA expert advisory ...
(Date:5/20/2013)... have mapped the significance of heredity for common ... examined whether different forms of the disease share ... ischemic stroke, peripheral arterial disease and atherosclerosis of ... have suffered different types of cardiovascular disease. , ... atherosclerosis of the aorta followed by peripheral arterial ...
(Date:5/20/2013)... Gilman Law LLP, a leading pharmacy ... lawsuits, is troubled by a new study that reveals ... type 2 diabetes drugs are growing. The analysis, ... found that 71 Byetta pancreatic cancer reports had been ... as of June 30, 2012. Overall, Byetta ...
(Date:5/20/2013)... Newport News, VA (PRWEB) May 20, 2013 ... Jeffrey Carlson successfully performed a procedure using SpineFrontier’s FacetFuse ... Fusion Device System. The operation took place on ... Hospital in Newport News, VA. The surgery was ... a 66 year-old, female patient. , Dr. Carlson described ...
(Date:5/20/2013)... The study comprised over 24,000 Finnish subjects and ... revealed that a panel of 28 genetic markers ... coronary heart disease (CHD) (10-year risk ≥20%) over ... is an important preventive strategy for CHD, because ... high-risk group. "The results indicate that genetic markers ...
Breaking Medicine News(10 mins):Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 2Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 3
(Date:5/17/2013)... 17, 2013 Medical devices are any medical ... product. In light of their different mechanisms, actions and ... more complicated than drug trails due to their unique ... instead of evaluating both safety and efficacy (which is ... is the same as the SFDA) evaluate MDs for ...
(Date:5/17/2013)... DIEGO , May 17, 2013  Sorrento ... that its Fast-Track Advanced Technology Small Business Technology ... Institute of Allergy and Infectious Diseases (NIAID), a ... supporting the development of novel human antibody therapeutics ... aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
Cached News: